Anesthesia
Analgesic efficacy of epidural ropivacaine 0.2% not improved by sufentanil
Published in Medical Devices and Surgical Technology Week, December 4th, 2005
Anesthesiologists in Germany conducted a "prospective, randomized, single-blind study" to "compare the analgesic effectiveness of postoperative epidural ropivacaine 0.2% with and without the addition of sufentanil following total hip replacement."
A total of "32 patients scheduled for elective hip replacement surgery received either ropivacaine 0.2% alone (n=16, R) or ropivacaine 0.2% together with sufentanil 1 microg/mL (n=16, RS) via continuous epidural infusion at a dose determined by the size of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Diagnostics
Modified flow cytometer detects infrared fluorescence - Medical Devices
Autotransfusion system reduces allogeneic blood use during endoluminal AAA repair - Medical Devices
Insignia I Ultra ventricular automatic capture is accurate and safe - Surgical Technology
Endoscopic membranectomy with a high-frequency-wave snare/cutter in upper GI tract effective - Surgical Technology
Stereotactic image guidance improves safety and efficiency of thoracoscopic discectomy - Adverse Drug Reaction
High-dose corticosteroid treatment reduces bone mineral density - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
